ACADIA PHARMACEUTICALS INC (ACAD) Stock Balance Sheet
NASDAQ:ACAD • US0042251084
Current stock price
20.99 USD
+0.25 (+1.21%)
At close:
20.87 USD
-0.12 (-0.57%)
Pre-Market:
| 2025 (2025-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 1.02M | 1.47M | 1.55M | N/A | |||
| Cash Equivalents | 819.69M | 45.00K | 269.00K | 114.80M | 147.40M | |||
| Marketable Securities | 641.99M | 436.40M | 250.21M | 302.00M | 373.30M | |||
| Receivables | 148.23M | 4.05M | 11.00K | 18.50K | 65.30M | |||
| Inventories | 34.67M | 21.95M | 35.82M | 6.60M | 7.90M | |||
| Other Current Assets | 59.53M | 25.00K | 33.00K | 5.30K | 23.90M | |||
| Total Current Assets | 1.06B | 5.13M | 1.78M | 1.58M | 617.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 54.87M | 50.79M | 56.47M | 61.60M | 66.30M | |||
| Investments And Advances | N/A | 306.31M | 8.78M | 11.16M | N/A | |||
| Intangibles | 108.89M | 119.78M | 65.49M | N/A | 0.00 | |||
| Other Non-Current Assets | 338.32M | 78.87M | 0.00 | 238.20K | 16.00M | |||
| Total Non-Current Assets | 502.08M | 306.31M | 8.78M | 11.40M | 82.30M | |||
| TOTAL ASSETS | 1.56B | 311.45M | 10.56M | 12.97M | 700.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 266.21M | 57.00K | 58.00K | 16.00K | 89.20M | |||
| Accounts Payable | 10.90M | 15.00K | 42.00K | 19.30K | 6.90M | |||
| Other Current Liabilities | N/A | 10.00K | 0.00 | 5.00K | N/A | |||
| Total Current Liabilities | 277.11M | 82.00K | 100.00K | 40.30K | 96.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | N/A | |||
| Other Non-Current Liabilities | 59.69M | 60.09M | 62.95M | 61.80M | 63.20M | |||
| Total Non-Current Liabilities | 59.69M | 0.00 | 0.00 | 0.00 | 63.10M | |||
| TOTAL LIABILITIES | 336.81M | 82.00K | 100.00K | 40.30K | 159.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.81B | -5.97M | -3.69M | -453.20K | -2.15B | |||
| Additional Paid In Capital | 3.04B | 297.06M | 13.23M | 12.62M | 2.69B | |||
| Common Shares | 16.00K | 20.28M | 917.00K | 768.20K | 0.00 | |||
| Other Shareholders' Equity | 1.45M | 292.00K | 24.00K | -1.00M | -200.00K | |||
| Shares Outstanding | 170.31M | 202.29M | 8.69M | 7.21M | 161.00M | |||
| Tangible Book Value per Share | 6.57 | 1.54 | 1.20 | 1.79 | 3.36 | |||
| Total Shareholders' Equity | 1.23B | 311.37M | 10.46M | 12.93M | 540.90M | |||
| TOTAL LIABILITIES AND EQUITY | 1.56B | 311.45M | 10.56M | 12.97M | 700.10M | |||
| Statistics | ||||||||
| Current Ratio | 3.83 | 62.62 | 17.81 | 39.13 | 6.43 | |||
| Return On Assets (ROA) | 25.00% | -0.73% | -30.64% | -8.93% | -23.98% | |||
| Return On Equity (ROE) | 31.86% | -0.73% | -30.93% | -8.96% | -31.04% | |||
| Return On Invested Capital (ROIC) | 6.43% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21